EMEA-002623-PIP01-19

Table of contents

Key facts

Active substance
Ondansetron (hydrochloride)
Therapeutic area
  • Neurology
  • Other
Decision number
P/0248/2020
PIP number
EMEA-002623-PIP01-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of alcohol use disorder
Route(s) of administration
Oral use
Contact for public enquiries
Adial Pharmaceuticals

E-mail: info@adialpharma.com
Tel. +1 4344229800

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating